This inventor holds 1 USPTO granted patent. Top assignee: Amgen Inc.. Active years: 2004.
Company Filing History:
Years Active: 2004
Title: Colin Gregg: Innovator in Protein Modification
Introduction
Colin Gregg is a notable inventor based in Newbury Park, CA (US). He has made significant contributions to the field of biochemistry, particularly in the area of protein modification. His work focuses on enhancing the biocompatibility and bioactivity of biologically active proteins.
Latest Patents
Colin Gregg holds a patent for the "Chemical modification of proteins to improve biocompatibility and bioactivity." This invention relates to novel methods for site-specific chemical modification of various proteins, resulting in compositions that exhibit improved biocompatibility and bioactivity. This advancement has the potential to impact various applications in medicine and biotechnology.
Career Highlights
Colin Gregg is associated with Amgen Inc., a leading biotechnology company. His role at Amgen allows him to work on cutting-edge research and development projects that aim to improve human health through innovative biotechnological solutions.
Collaborations
Colin has collaborated with Olaf B Kinstler, further enhancing the scope and impact of his research in the field of protein modification.
Conclusion
Colin Gregg's innovative work in the chemical modification of proteins showcases his commitment to advancing biocompatibility and bioactivity in biotechnological applications. His contributions are vital to the ongoing development of effective medical solutions.